Latest filing published 02 Jan 2015 for Alaunos Therapeutics, Inc., €142k.
Insider track record
No signal scores available.
Closed purchases
Based on 2 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- -66.5%Entry US$385.50 · Close at T+365 US$129.00
- -47.6%Entry US$790.50 · Close at T+365 US$414.00
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Jonathan Lewis: trading record in brief
This profile gathers the share dealings of Jonathan Lewis across 2 companies, led by Alaunos Therapeutics, Inc. and Delcath Systems, Inc. In total, 22 filings cover trades dated from 12 March 2007 to 30 December 2014.
No open-market sale appears; the market trades are 2 purchases worth €14k. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Other entries cover 16 share grants and 2 option exercises.
The newest entry dates from 2 January 2015: a share grant of €142k, in Alaunos Therapeutics, Inc. The last purchase on record was published on 10 December 2007, which is 6,909 days ago. The median gap between a trade and its publication by SEC (Form 4) is 3 days. For comparison, the SEC allows two business days to file a Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Jonathan Lewis
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 34,261 shares@ US$5.03Common StockSEC:0001209191-15-000216:0
- 25,674 shares@ US$0.08Common StockSEC:0001209191-14-002064:0
- 242,979 shares@ US$0.08Common StockSEC:0001209191-14-002064:1
- 15,023 shares@ US$4.34Common StockSEC:0001209191-14-000751:0
- 14,715 shares@ US$4.21Common StockSEC:0001209191-13-001321:0
- 21,475 shares@ US$4.16Common StockSEC:0001209191-13-001321:1
- 102,781 shares0Common StockSEC:0001209191-12-001308:0
- 21,475 shares@ US$4.41Common StockSEC:0001209191-12-001308:1
- 15,190 shares@ US$5.14Common Stock, $.001 par valueSEC:0001179110-11-000821:0
- 21,475 shares@ US$4.77Common Stock, $.001 par valueSEC:0001179110-11-000073:0
- 128,850 shares@ US$3.95Common Stock, $.001 par valueSEC:0001179110-10-014225:0
- 12,650 shares@ US$3.10Common Stock, $.001 par valueSEC:0001179110-10-000979:0
- 150,000 shares0Common Stock, $.001 par valueSEC:0001179110-10-000191:0
- 47,625 shares@ US$3.66Common Stock, $.001 par valueSEC:0001179110-09-016494:0
- 300,000 shares0Common Stock, $.001 par valueSEC:0001179110-09-013635:0
- 150 shares0Common Stock, $.001 par valueSEC:0001179110-09-007914:0
- 300 shares0Common Stock, $.001 par valueSEC:0001179110-09-007914:1
- 150,000 shares@ US$0.83Common Stock, $.001 par valueSEC:0001144204-08-068019:0
- 100,000 sharesCommon Stock, $.001 par valueSEC:0001179110-08-001512:0
- 3,000 shares@ US$3.00Common Stock, $.001 par valueSEC:0001179110-07-022987:0Canonical exit: 6 Mar 2008 (T+90)
- 2,000 shares@ US$4.95Common Stock, $.001 par valueSEC:0001179110-07-005988:0Canonical exit: 10 Jun 2007 (T+90)
21 of 21 declarations
